Sy CL, Chen PY, Cheng CW, Huang LJ, Wang CH, Chang TH, Chang YC, Chang CJ, Hii IM, Hsu YL, Hu YL, Hung PL, Kuo CY, Lin PC, Liu PY, Lo CL, Lo SH, Ting PJ, Tseng CF, Wang HW, Yang CH, Lee SS, Chen YS, Liu YC, Wang FD (2022) Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms. J Microbiol Immunol Infect 55(3):359–386. https://doi.org/10.1016/j.jmii.2022.02.001
Kim AJ, Lee JY, Choi SA, Shin WG (2016) Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients. Int J Antimicrob Agents 48(4):381–387. https://doi.org/10.1016/j.ijantimicag.2016.06.022
Article CAS PubMed Google Scholar
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285–292. https://doi.org/10.1093/cid/cir034
Sinha Ray A, Haikal A, Hammoud KA, Yu ASL (2016) Vancomycin and the risk of AKI: a systematic review and meta-analysis. Clin J Am Soc Nephrol 11(12):2132–2140. https://doi.org/10.2215/CJN.05920616
Article PubMed PubMed Central Google Scholar
Huang J, Xu D, Yang L (2020) Acute kidney injury in Asia: disease burden. Semin Nephrol 40(5):443–455. https://doi.org/10.1016/j.semnephrol.2020.08.001
van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 57(2):734–744. https://doi.org/10.1128/AAC.01568-12
Article CAS PubMed PubMed Central Google Scholar
Kim JY, Yee J, Yoon HY, Han JM, Gwak HS (2022) Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis. Br J Clin Pharmacol 88(9):3977–3989. https://doi.org/10.1111/bcp.15429
Article CAS PubMed Google Scholar
James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ (2015) A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis 66(4):602–612. https://doi.org/10.1053/j.ajkd.2015.02.338
Article PubMed PubMed Central Google Scholar
Perin N, Roger C, Marin G, Molinari N, Evrard A, Lavigne JP, Barbar S, Claret PG, Boutin C, Muller L, Lipman J, Lefrant JY, Jaber S, Roberts JA (2020) Vancomycin serum concentration after 48 h of administration: a 3-years survey in an intensive care unit. Antibiotics (Basel) 9(11):793. https://doi.org/10.3390/antibiotics9110793
Fuhrman DY, Kane-Gill S, Goldstein SL, Priyanka P, Kellum JA (2018) Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16–25 years of age treated in an adult intensive care unit. Ann Intensive Care 8(1):26. https://doi.org/10.1186/s13613-018-0373-y
Article PubMed PubMed Central Google Scholar
Kim MY, Park JH, Kang NR, Jang HR, Lee JE, Huh W, Kim YG, Kim DJ, Hong SC, Kim JS, Oh HY (2014) Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage. J Neurosurg 120(6):1340–1348. https://doi.org/10.3171/2013.12.JNS13888
Hoste L, Dubourg L, Selistre L, De Souza VC, Ranchin B, Hadj-Aïssa A, Cochat P, Martens F, Pottel H (2014) A new equation to estimate the glomerular filtration rate in children, adolescents and young adults. Nephrol Dial Transplant 29(5):1082–1091. https://doi.org/10.1093/ndt/gft277
Article CAS PubMed Google Scholar
Pan KM, Wu Y, Chen C, Chen ZZ, Xu JA, Cao L, Xu Q, Wu W, Dai PF, Li XY, Lv QZ (2018) Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study. Br J Clin Pharmacol 84(8):1706–1718. https://doi.org/10.1111/bcp.13594
Article CAS PubMed PubMed Central Google Scholar
Purnomo AF, Permana KR, Daryanto B (2021) Acute kidney injury following mannitol administration in traumatic brain injury: a meta-analysis. Acta Inform Med 29(4):270–274. https://doi.org/10.5455/aim.2021.29.270-274
Article PubMed PubMed Central Google Scholar
Nau R (2000) Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet 38(1):23–40. https://doi.org/10.2165/00003088-200038010-00002
Article CAS PubMed Google Scholar
Huang M, Wu H, Zhou J, Xu M, Zhou S (2018) Efficacy of vancomycin on gram-positive bacterial infection in elderly critical patients and risk factors associated with nephrotoxicity. Arch Iran Med 21(8):349–355
Perner A, Prowle J, Joannidis M, Young P, Hjortrup PB, Pettilä V (2017) Fluid management in acute kidney injury. Intensive Care Med 43:807–815. https://doi.org/10.1007/s00134-017-4817-x
Epstein FH, Badr KF, Ichikawa I (1988) Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med 319:623–629. https://doi.org/10.1056/NEJM198809083191007
Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288:1087–1090. https://doi.org/10.1056/NEJM197305242882102
Article CAS PubMed Google Scholar
Leete J, Wang C, López-Hernández FJ, Layton AT (2022) Determining risk factors for triple whammy acute kidney injury. Math Biosci 347:108809. https://doi.org/10.1016/j.mbs.2022.108809
Article CAS PubMed Google Scholar
Tookhi RF, Kabli NA, Huntul MA, Thabit AK (2021) Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity. Intern Emerg Med 16(4):975–979. https://doi.org/10.1007/s11739-020-02624-5
Article CAS PubMed Google Scholar
Wali HA, Alabdulwahed MA, Al-Hussain GY, Alabbad MA, Al-Khalaf LH, Alhumaidi SS, Alhussain K, Alomair SM, Almulhim AS (2023) Assessment of knowledge, attitude, and practices of acute kidney injury incidence with co-administration of piperacillin/tazobactam and vancomycin among healthcare workers: a cross-sectional study. Saudi Pharm J 31(6):904–910. https://doi.org/10.1016/j.jsps.2023.04.020
Article CAS PubMed PubMed Central Google Scholar
Zhang T, Cheng H, Li Y, Dong YZ, Zhang Y, Cheng XL, Wang AM, Dong YL (2019) Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem. J Clin Pharm Ther 44(3):440–446. https://doi.org/10.1111/jcpt.12806
Article CAS PubMed Google Scholar
Chen AY, Deng CY, Calvachi-Prieto P, Armengol de la Hoz MÁ, Khazi-Syed A, Chen C, Scurlock C, Becker CD, Johnson AEW, Celi LA, Dagan A (2023) A large-scale multicenter retrospective study on nephrotoxicity associated with empiric broad-spectrum antibiotics in critically ill patients. Chest 164(2):355–368. https://doi.org/10.1016/j.chest.2023.03.046
Article CAS PubMed Google Scholar
Moon YS, Chung KC, Gill MA (1997) Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Clin Infect Dis 24(Suppl 2):S249-255. https://doi.org/10.1093/clinids/24.supplement_2.s249
Article CAS PubMed Google Scholar
Lee JY, Park JT, Joo YS, Lee C, Yun HR, Yoo TH, Kang SW, Choi KH, Ahn C, Oh KH, Sung S, Kim SW, Lee J, Han SH, KNOW-CKD (Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators (2021) Association of blood pressure with the progression of CKD: findings from KNOW-CKD study. Am J Kidney Dis 78(2):236–245. https://doi.org/10.1053/j.ajkd.2020.12.013
Li L, Zhang L, Li S, Xu F, Li L, Li S, Lyu J, Yin H (2022) Effect of first trough vancomycin concentration on the occurrence of AKI in critically Ill patients: a retrospective study of the MIMIC-IV database. Front Med (Lausanne) 9:879861. https://doi.org/10.3389/fmed.2022.879861
留言 (0)